{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T11:14:10Z","timestamp":1791112450573,"version":"4.1.0"},"reference-count":38,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2009,4,24]],"date-time":"2009-04-24T00:00:00Z","timestamp":1240531200000},"content-version":"vor","delay-in-days":8503,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Internal Medicine"],"published-print":{"date-parts":[[1986,1,12]]},"abstract":"<jats:p><jats:bold>ABSTRACT. <\/jats:bold> Hyper\u2010\u03b1\u2010triglyceridemia is a rare dyslipoproteinemia characterized by a pronounced increase in the concentration of triglycerides in the plasma high density lipoprotein (HDL) fraction. One case with this condition, an apparently healthy 61\u2010year\u2010old man, has been studied. Additional lipoprotein abnormalities were present, such as abnormally cholesterol\u2010rich very low density lipoproteins (VLDL) with retarded electrophoretic mobility (\u03b2\u2010VLDL) and triglyceride enrichment of low density lipoproteins\u2010(LDL). The patient's plasma concentration of apolipoproteins A\u2010I, A\u2010II and B were normal and those of C\u2010I, C\u2010II, C\u2010III and E were elevated. No abnormal forms of the soluble apolipoproteins of VLDL and high density lipoproteins (HDL) were found after analysis by isoelectric focusing. Lecithin: cholesterol acyltransferase activities, plasma cholesterol esterification rates and lipid transfer protein activities were normal. Post\u2010heparin plasma activity of hepatic lipase was virtually absent and that of lipoprotein lipase was reduced by 50%. In plasma of this patient, HDL was almost exclusively present as large triglyceride\u2010rich particles corresponding in size to particles of the HDL<jats:sub>2<\/jats:sub> density fraction. The only brother of the patient also had hyper\u2010\u03b1\u2010triglyceridemia together with the other lipoprotein abnormalities described for the index case and deficiency of postheparin plasma activity of hepatic lipase. The findings presented below support the hypothesis that one primary function of hepatic lipase is associated with degradation of plasma HDL<jats:sub>2<\/jats:sub>. Deficiency of this enzyme activity thus causes accumulation of HDL<jats:sub>2<\/jats:sub> in plasma leading to hyper\u2010\u03b1\u2010triglyceridemia. The results further suggest that the abnormal chemical and electrophoretic properties of VLDL and LDL in plasma from the patient, reminiscent of type III hyperlipoproteinemia, are secondary to the lack of the action of hepatic lipase on the HDL particles.<\/jats:p>","DOI":"10.1111\/j.0954-6820.1986.tb03337.x","type":"journal-article","created":{"date-parts":[[2010,8,15]],"date-time":"2010-08-15T07:05:44Z","timestamp":1281855944000},"page":"435-447","source":"Crossref","is-referenced-by-count":90,"title":["Deficiency of Hepatic Lipase Activity in Post\u2010heparin Plasma in Familial Hyper\u2010\u03b1\u2010Triglyceridemia"],"prefix":"10.1111","volume":"219","author":[{"given":"LARS A.","family":"CARLSON","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LEIF","family":"HOLMQUIST","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PETER","family":"NILSSON\u2010EHLE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,4,24]]},"reference":[{"key":"e_1_2_2_2_2","first-page":"9","volume-title":"Blood and arterial wall in atherogenesis and arterial thrombosis","author":"Carlson LA","year":"1975"},{"key":"e_1_2_2_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9150(80)90251-8"},{"key":"e_1_2_2_4_2","first-page":"205","volume-title":"Metabolic risk factors in ischemic cardiovascular disease","author":"Nikkil\u00e4 EA","year":"1982"},{"key":"e_1_2_2_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-291X(81)80217-3"},{"key":"e_1_2_2_6_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI111624"},{"key":"e_1_2_2_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9150(82)90136-8"},{"key":"e_1_2_2_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0954-6820.1985.tb08846.x"},{"key":"e_1_2_2_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0954-6820.1985.tb08847.x"},{"key":"e_1_2_2_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.1982.tb00938.x"},{"key":"e_1_2_2_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0954-6820.1983.tb03713.x"},{"key":"e_1_2_2_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/0005-2795(77)90196-9"},{"key":"e_1_2_2_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(80)80783-6"},{"key":"e_1_2_2_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0954-6820.1984.tb04980.x"},{"key":"e_1_2_2_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0954-6820.1985.tb03252.x"},{"key":"e_1_2_2_16_2","first-page":"194","article-title":"Rapid, simple and specific assays for lipoprotein lipase and hepatic lipase","volume":"3","author":"Nilsson\u2010Ehle P.","year":"1977","journal-title":"Artery"},{"key":"e_1_2_2_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/0009-8981(84)90024-X"},{"key":"e_1_2_2_18_2","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1093\/clinchem\/30.9.1568","article-title":"Two methods compared for measuring lipase activity in plasma after heparin administration","volume":"30","author":"Ehnholm C.","year":"1984","journal-title":"Clin Chem"},{"key":"e_1_2_2_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-1759(80)90051-4"},{"key":"e_1_2_2_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/0009-8981(82)90242-X"},{"key":"e_1_2_2_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0009-8981(82)90384-9"},{"key":"e_1_2_2_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/0009-8981(86)90146-4"},{"key":"e_1_2_2_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/0005-2760(84)90265-0"},{"key":"e_1_2_2_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9150(75)90054-4"},{"issue":"637","key":"e_1_2_2_25_2","article-title":"Studies on serum lipoproteins and lipid metabolism. Analysis of a random sample of 40 year old men","author":"Olsson AG","year":"1980","journal-title":"Acta Med Scand"},{"key":"e_1_2_2_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-2275(20)40633-9"},{"key":"e_1_2_2_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9150(83)90061-8"},{"issue":"580","key":"e_1_2_2_28_2","article-title":"Studies in asymptomatic primary hyperlipidaemia. I. Types of hyperlipoproteinaemias and serum lipoprotein concentrations, compositions and interrelations","author":"Olsson AG","year":"1975","journal-title":"Acta Med Scand"},{"key":"e_1_2_2_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9150(72)90083-4"},{"key":"e_1_2_2_30_2","first-page":"655","volume-title":"The metabolic basis of inherited disease","author":"Brown MS","year":"1983"},{"key":"e_1_2_2_31_2","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/BF02909306","article-title":"Role in lipoprotein metabolism and pathophysiology of hyperlipoproteinemia type III","author":"Uterman G.","year":"1982","journal-title":"Ric Clin Lab"},{"key":"e_1_2_2_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/0009-8981(81)90146-7"},{"key":"e_1_2_2_33_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI110717"},{"key":"e_1_2_2_34_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.1980.tb02090.x"},{"key":"e_1_2_2_35_2","doi-asserted-by":"crossref","first-page":"6079","DOI":"10.1016\/S0021-9258(18)50521-4","article-title":"In vitro production of human plasma low density lipoprotein\u2010like particles. A model for very low density lipoprotein catabolism","volume":"254","author":"Deckelbaum RJ","year":"1979","journal-title":"J Biol Chem"},{"issue":"255","key":"e_1_2_2_36_2","article-title":"Plasma lipoprotein alterations in thyroid dysfunction. Roles of lipoprotein lipase, hepatic lipase and LCAT","volume":"103","author":"Valdemarsson S.","year":"1983","journal-title":"Acta Endocrinol (Copenh)"},{"key":"e_1_2_2_37_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.1982.tb00690.x"},{"key":"e_1_2_2_38_2","doi-asserted-by":"crossref","first-page":"6509","DOI":"10.1016\/S0021-9258(20)65171-7","article-title":"Reversible modification of human plasma low density lipoproteins towards triglyceride\u2010rich precursors. A mechanism for losing excess cholesterol esters","volume":"257","author":"Deckelbaum RJ","year":"1982","journal-title":"J Biol Chem"},{"key":"e_1_2_2_39_2","first-page":"85","volume-title":"Treatment of hyperlipoproteinemia","author":"Deckelbaum RJ","year":"1984"}],"container-title":["Acta Medica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.0954-6820.1986.tb03337.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.0954-6820.1986.tb03337.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T12:12:36Z","timestamp":1697371956000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.0954-6820.1986.tb03337.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1986,1,12]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1986,1,12]]}},"alternative-id":["10.1111\/j.0954-6820.1986.tb03337.x"],"URL":"https:\/\/doi.org\/10.1111\/j.0954-6820.1986.tb03337.x","archive":["Portico"],"relation":{},"ISSN":["0001-6101"],"issn-type":[{"value":"0001-6101","type":"print"}],"subject":[],"published":{"date-parts":[[1986,1,12]]}}}